Verapamil Hydrochloride

Product NDC: 0378-6380
11-digit product format: 003786380
Labeler code: 0378
Product ID: 0378-6380_c63ca9bc-5c77-4e53-8adf-9cfd16bfe012
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: verapamil hydrochloride
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: ANDA075138
Marketing category: ANDA
Marketing start: 1999-05-20
Substance: VERAPAMIL HYDROCHLORIDE
Active strength: 180 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075138-001	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20
A075138-002	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20
A075138-003	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075138-001	AB
A075138-002	AB
A075138-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-002	VERAPAMIL HYDROCHLORIDE	180MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-003	VERAPAMIL HYDROCHLORIDE	240MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075138-001	VERAPAMIL HYDROCHLORIDE	120MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	1999-04-20	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075138-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075138-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075138-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075138-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075138-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075138-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075138-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075138-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075138-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075138-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075138-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075138-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075138-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075138-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075138-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075138-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075138-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075138-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075138-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075138-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Verapamil Hydrochloride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
VERAPAMIL HYDROCHLORIDE	180 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
V3888OEY5R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
897612	Internal RxNorm lookup
897618	Internal RxNorm lookup
897624	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
c86084bc-33aa-eece-5a96-6c0dad2d1a32	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4	Product name	2	20230103
33ad674d-d105-6aa5-02fa-95ae4329b8cd	Product name	2	20180809
3279bd6d-5b02-e60b-3857-c853a2deb2dd	Product name	2	20170713
8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a	Product name	1	20140508
940a1faa-2df8-cc65-be37-1b97984b4ea3	Product name	1	20140508
d3b67bc2-0e96-e3ec-06a9-90afcc07bf13	Product name	1	20140508
e2fcd66c-a043-3187-790d-b0342deb1149	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0378-6380-01	Verapamil Hydrochloride	100 in 1 BOTTLE, PLASTIC	CAPSULE, EXTENDED RELEASE	100		18

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0378-6380-01	EA - Each	0378-6380	19362b22-befe-494b-abfe-72537ca3eefc	1	2012-07-24
0378-6380-93	EA - Each	0378-6380	956b774b-d823-47a8-b0cc-5f6e8846aad3	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
VERAPAMIL HYDROCHLORIDE	ACTIVE INGREDIENT	V3888OEY5R	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
VERAPAMIL	ACTIVE MOIETY	CJ0O37KU29	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
DIBUTYL SEBACATE	INACTIVE INGREDIENT	4W5IH7FLNY	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
DIETHYL PHTHALATE	INACTIVE INGREDIENT	UF064M00AF	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
FD&C GREEN NO. 3	INACTIVE INGREDIENT	3P3ONR6O1S	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
GELATIN	INACTIVE INGREDIENT	2G86QN327L	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
OLEIC ACID	INACTIVE INGREDIENT	2UMI9U37CP	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
SHELLAC	INACTIVE INGREDIENT	46N107B71O	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
SUCROSE	INACTIVE INGREDIENT	C151H8M554	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0378-6380	VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	18	Current NDC, Legacy NDC, 1 package rows	20241211_c86084bc-33aa-eece-5a96-6c0dad2d1a32.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Safecor Health LLC	bf7b5037-7355-4788-b17b-323c18a5aee7	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075138 application number: ANDA075138
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Mylan Institutional Inc.	3bee2d26-138c-4641-a217-a38d3d657461	2025-07-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075138 application number: ANDA075138
Verapamil Hydrochloride	VERAPAMIL HYDROCHLORIDE	Mylan Pharmaceuticals Inc.	c86084bc-33aa-eece-5a96-6c0dad2d1a32	2021-06-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075138 application number: ANDA075138 ndc (product): 0378-6380

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V3888OEY5R	VERAPAMIL HYDROCHLORIDE	152-11-4	VERAPAMIL HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
897612	verapamil HCl 120 MG 24HR Extended Release Oral Capsule	PSN	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897618	verapamil HCl 180 MG 24HR Extended Release Oral Capsule	PSN	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897624	verapamil HCl 240 MG 24HR Extended Release Oral Capsule	PSN	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897612	24 HR verapamil hydrochloride 120 MG Extended Release Oral Capsule	SCD	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897618	24 HR verapamil hydrochloride 180 MG Extended Release Oral Capsule	SCD	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897624	24 HR verapamil hydrochloride 240 MG Extended Release Oral Capsule	SCD	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897612	verapamil hydrochloride 120 MG 24HR Extended Release Oral Capsule	SY	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897618	verapamil hydrochloride 180 MG 24 HR Extended Release Oral Capsule	SY	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18
897624	verapamil hydrochloride 240 MG 24HR Extended Release Oral Capsule	SY	c86084bc-33aa-eece-5a96-6c0dad2d1a32	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0378-6380-01	00378638001	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-6380-01)	1999-05-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Verapamil Hydrochloride - Mylan Pharmaceuticals Inc.	Mylan Pharmaceuticals Inc.	2021-06-21	HUMAN PRESCRIPTION DRUG LABEL	18